Lataa...
Current and Future Molecular Testing in NSCLC, What Can We Expect from New Sequencing Technologies?
Recent changes in lung cancer care, including new approvals in first line and the introduction of high-throughput molecular technologies in routine testing led us to question ourselves on how deeper molecular testing may be helpful for the optimal use of targeted drugs. In this article, we review re...
Tallennettuna:
| Julkaisussa: | J Clin Med |
|---|---|
| Päätekijät: | , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
MDPI
2018
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6024886/ https://ncbi.nlm.nih.gov/pubmed/29890761 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm7060144 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|